about
RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlationComparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer.Successful delivery after conservative resectoscopic surgery in a patient with a uterine tumor resembling ovarian sex cord tumor with myometrial invasionDifferential expression of the epigenetic methylation-related protein DNMT1 by breast cancer molecular subtype and stromal histology.Clinical value of ezrin expression in primary osteosarcoma.Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?Inflammatory pseudotumor of the liver treated by hepatic resection: a case report.The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions.Extremely Well-Differentiated Papillary Thyroid Carcinoma Resembling Adenomatous Hyperplasia Can Metastasize to the Skull: A Case Report.Expression of Epstein-Barr virus and granzyme B in cytologic smears of histiocytic necrotizing lymphadenitis.Male Infertility Associated with a Supernumerary Marker Chromosome.Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas.Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma
P50
Q33599429-222CB5A2-D9D5-4322-BAD6-1F6C83BAF9C9Q35435580-573DB273-1BCF-4C45-8643-3071A94A2AB2Q36107616-F41A786D-B54B-4D25-9BEA-45927AE94A1AQ36793525-F64B0372-8B2D-4CBC-A56E-143B35C8C26FQ37376890-4CD6DA9E-985E-4396-8901-0FFA2C8F18FAQ39502253-135B9F5A-6A3E-4A18-9DE8-33D21EF58BA5Q40485356-A8D3DA70-D6C9-412C-8302-E792CE620DA4Q41686062-AFD45D55-D1F5-4818-96D5-085349EEAB56Q42363609-9BABFC66-ADC9-4848-AC9B-7551C858B02FQ45369094-662101C6-C01D-4BFF-B191-2976A2E735CBQ47134572-04E0B517-73D6-43AE-B75D-09541204C8FDQ47669695-A186F327-1C72-4060-8850-46BF3C7B53DFQ48393757-D25C71DF-C23C-4A7E-9090-EC902E813505Q52886407-7D1FD180-84C9-42C1-8B4C-734793A2410CQ53607051-3719116A-259B-4D82-8E6B-4EA2BDA39874Q85054747-6B19C736-0399-448D-AEAD-83E8FAA3D71A
P50
description
investigador
@es
researcher
@en
name
Eunah Shin
@en
Eunah Shin
@nl
type
label
Eunah Shin
@en
Eunah Shin
@nl
prefLabel
Eunah Shin
@en
Eunah Shin
@nl
P108
P31
P496
0000-0001-5961-3563